Insulin Glargine

  title={Insulin Glargine},
  author={K. McKeage and K. Goa},
  • K. McKeage, K. Goa
  • Published 2012
  • Medicine
  • Drugs
  • SummaryAbstractInsulin glargine is a recombinant human insulin analogue produced by DNA technology using a nonpathogenic strain of Escherichia coli. Two modifications of human insulin result in a stable molecule which is soluble in slightly acidic conditions (pH 4.0) and precipitates in the neutral pH of subcutaneous tissue. Because of these properties, absorption of insulin glargine is delayed and the analogue provides a fairly constant, basal insulin supply without peaks in plasma insulin… CONTINUE READING
    18 Citations
    Insulin Glargine
    • 20
    Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.
    • 17
    Transgenic Expression and Identification of Recombinant Human Proinsulin in Peanut
    Insulin Therapy: The Old, the New and the Novel-An Overview.
    • 2
    Production of proinsulin in marker-free transgenic tobacco plants using CRE/loxP system


    Insulin Glargine
    • 13
    Insulin glargine: the first clinically useful extended-acting insulin in half a century?
    • P. Home
    • Medicine
    • Expert opinion on investigational drugs
    • 1999
    • 27
    • Highly Influential
    Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
    • 434
    • Highly Influential
    • PDF
    Insulin analogs with improved pharmacokinetic profiles.
    • Brange, Vølund
    • Medicine, Biology
    • Advanced drug delivery reviews
    • 1999
    • 191
    • Highly Influential